文献速递传染病防控与疫情报告免疫规划

2018年VASE会议:志贺菌与产肠毒素大肠杆菌疫苗研究综述

Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.
PubMed 文献 · Vaccine · 2019-01-01

本文总结2018年6月在墨西哥城召开的第二届VASE会议内容,该会议汇集全球专家讨论志贺菌和产肠毒素大肠杆菌(ETEC)疫苗研发进展。会议通过全会、海报和研讨会形式,涵盖疾病负担、流行病学、卫生经济学、宿主参数与基因组学、临床前评估及临床试验等议题,旨在加速这两种细菌病原体疫苗的上市进程。

要点

  • 志贺菌和ETEC感染导致的腹泻病及长期后遗症受到关注
  • 疫苗研发探索新型保守抗原以提升有效性
  • 部分候选疫苗已进入临床试验阶段

核心结论

  • 会议旨在加速志贺菌和ETEC疫苗的研发与上市进程。

研究设计与样本

  • PATH于2018年6月在墨西哥城主办第二届VASE会议,汇集全球专家通过全会、海报和研讨会交流。

主要发现

  • 许多报告认识到志贺菌和ETEC感染所致腹泻病及长期后遗症的重要性。
  • 其他报告探索了疫苗研发新策略,包括寻找新型可能保守的抗原以开发更有效疫苗。
  • 部分候选疫苗正推进临床试验,研发取得进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PATH hosted the second Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference in Mexico City in June 2018, again providing experts from around the world an opportunity to participate in a highly collaborative forum to discuss progress in the development of new enteric vaccines. Through a combination of plenary sessions and posters, keynote presentations, and workshops, the 2018 VASE Conference aimed to accelerate communication and progress among those working to achieve the goal of licensed vaccines against these two bacterial pathogens. Many presentations recognized the importance of diarrheal disease and long-term sequelae caused by infections with Shigella and enterotoxigenic E. coli (ETEC). Other presentations explored new strategies for vaccine development, including the search for novel, possibly conserved, antigens for more effective vaccines. Much progress is being made as some vaccine candidates are now moving through clinical trials. Research presented in oral and poster presentations at the VASE Conference covered a range of topics, including: the global burden of disease, epidemiology, and health economics; host parameters and genomics that predict responses to infection and disease; preclinical evaluations of vaccine antigens and models of enteric diseases; and vaccine candidates in clinical trials and human challenge studies. This article reviews key points and highlighted research presented in each of the plenary conference sessions and poster presentations at the 2018 VASE Conference.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Barry E, Cassels F, Riddle M, et al. Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference. Vaccine. 2019. PMID: 31358236. doi:10.1016/j.vaccine.2019.02.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。